PATHALYS
Fourth Extension - Granted
Status timeline
- 15 Dec 2023Application filedNew Application Entered
- 16 Jul 2024Assigned to an examining attorneyAssigned To Examiner
- 19 Jul 2024Approved for publicationApproved For Pub - Principal Register
- 27 Aug 2024Published for oppositionPublished For Opposition
- 22 Oct 2024Notice of allowance issued — statement of use requiredNoa E-Mailed - Sou Required From Applicant
- 15 Apr 2025Statement-of-use extension 1 grantedSou Extension 1 Granted
- 10 Oct 2025Statement-of-use extension 2 grantedSou Extension 2 Granted
- 26 Mar 2026Statement-of-use extension 3 grantedSou Extension 3 Granted
All 28 USPTO events
| 2026-09-01 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-08-31 | Sou Teas Extension Received |
| 2026-08-31 | Sou Extension 4 Filed |
| 2026-08-31 | Sou Extension 4 Granted |
| 2026-03-27 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-03-26 | Sou Teas Extension Received |
| 2026-03-26 | Sou Extension 3 Filed |
| 2026-03-26 | Sou Extension 3 Granted |
| 2025-10-10 | Sou Teas Extension Received |
| 2025-10-10 | Sou Extension 2 Filed |
| 2025-10-10 | Sou Extension 2 Granted |
| 2025-10-10 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-04-15 | Sou Extension 1 Granted |
| 2025-04-15 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-04-14 | Sou Teas Extension Received |
| 2025-04-14 | Sou Extension 1 Filed |
| 2024-10-22 | Noa E-Mailed - Sou Required From Applicant |
| 2024-08-27 | Published For Opposition |
| 2024-08-27 | Official Gazette Publication Confirmation E-Mailed |
| 2024-08-07 | Notification Of Notice Of Publication E-Mailed |
| 2024-07-19 | Examiners Amendment -Written |
| 2024-07-19 | Examiners Amendment E-Mailed |
| 2024-07-19 | Notification Of Examiners Amendment E-Mailed |
| 2024-07-19 | Examiner's Amendment Entered |
| 2024-07-19 | Approved For Pub - Principal Register |
| 2024-07-16 | Assigned To Examiner |
| 2024-03-24 | New Application Office Supplied Data Entered |
| 2023-12-15 | New Application Entered |
Goods & services
Class 5 Pharmaceuticals & supplements
Pharmaceutical and biological preparations for treating hemodialysis patients; calcimimetics in the nature of pharmaceuticals that mimic the action of calcium on tissues; Pharmaceutical and biological preparations for use in nephrology and endocrinology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions of the kidneys and glands; Pharmaceutical and biological preparations for treating and managing chronic kidney disease (CKD), end stage renal disease (ESRD), secondary hyperparathyroidism (SHPT), and conditions arising from complications of kidney disease and hemodialysis; Therapeutic agents for affecting calcium-s…
Class 42 Technology & SaaS
Research and development in the fields of pharmaceuticals, and nephrology, diseases, disorders, and conditions of the kidneys; Providing medical scientific research information in the fields of nephrology, diseases, disorders, and conditions of the kidneys, and pharmaceuticals.
Source & freshness
Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 31 Aug 2026; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.